DeepMed Research

University of Virginia

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1819-01-01

Employees: 10K

Market Cap: -

Website: http://www.virginia.edu

Clinical Trials

Effectiveness of a Web-based Intervention for Guardians of Children Whose One Parent Has Murdered the Other

Not Applicable

Withdrawn

Conditions: Post-Traumatic Stress Disorder

Interventions: Behavioral: Interactive Healthcare Communication Application
Behavioral: Control Web sites

First Posted Date: 2008-08-18

Last Posted Date: 2015-08-07

Lead Sponsor: University of Virginia

Registration Number: NCT00737035

Locations: 🇺🇸
University of Virginia, Charlottesville, Virginia, United States

Phase I Study of Induction Therapy With VELCADE and Vorinostat in Patients With Surgically Resectable Non-Small Cell Lung Cancer

Phase 1

Completed

Conditions: Non Small Cell Lung Cancer

Interventions: Drug: Velcade and Vorinostat

First Posted Date: 2008-08-11

Last Posted Date: 2017-05-04

Lead Sponsor: University of Virginia

Target Recruit Count: 21

Registration Number: NCT00731952

Locations: 🇺🇸
University of Virginia, Charlottesville, Virginia, United States

Improving the Sleep of Cancer Patients Using an Internet-Based Program

Not Applicable

Completed

Conditions: Cancer
Insomnia

Interventions: Behavioral: Sleep Healthy Using the Internet (SHUTi)
Behavioral: Hypnosis recordings

First Posted Date: 2008-07-16

Last Posted Date: 2010-02-25

Lead Sponsor: University of Virginia

Target Recruit Count: 22

Registration Number: NCT00716872

Locations: 🇺🇸
University of Virginia Department of Psychiatry & Neurobehavioral Sciences, Charlottesville, Virginia, United States

Lifestyle Intervention's Impact on Health Care Costs

Not Applicable

Completed

Conditions: Diabetes Mellitus, Type 2
Obesity

Interventions: Behavioral: Usual medical care
Behavioral: Lifestyle Case management

First Posted Date: 2008-07-16

Last Posted Date: 2008-07-16

Lead Sponsor: University of Virginia

Target Recruit Count: 147

Registration Number: NCT00717158

Locations: 🇺🇸
University of Virginia School of Medicine, Charlottesville, Virginia, United States

New Medication Treatment for Stimulant Dependence

Phase 2

Completed

Conditions: Cocaine Dependence

Interventions: Drug: Placebo
Drug: Ondansetron

First Posted Date: 2008-06-03

Last Posted Date: 2021-11-11

Lead Sponsor: University of Virginia

Target Recruit Count: 108

Registration Number: NCT00689572

Locations: 🇺🇸
University of Virginia Center for Addiction Research and Education, Richmond, Virginia, United States

Omega 3 Fish Oil Supplements vs. Placebo for Patients With Non-alcoholic Steatohepatitis (NASH)

Phase 2

Completed

Conditions: Fatty Liver
Non-alcoholic Steatohepatitis

Interventions: Drug: Placebo
Drug: Omega 3 Fish Oil supplements

First Posted Date: 2008-05-21

Last Posted Date: 2015-05-29

Lead Sponsor: University of Virginia

Target Recruit Count: 41

Registration Number: NCT00681408

Locations: 🇺🇸
University of Virginia School of Medicine, Charlottesville, Virginia, United States

Ondansetron With Olanzapine for the Treatment of Alcohol Dependence: A Preliminary Clinical Trial

Phase 2

Completed

Conditions: Alcohol Dependence

Interventions: Drug: Placebo
Drug: Ondansetron
Drug: Olanzapine

First Posted Date: 2008-05-15

Last Posted Date: 2009-01-30

Lead Sponsor: University of Virginia

Target Recruit Count: 40

Registration Number: NCT00678457

Locations: 🇺🇸
UVA CARE, Charlottesville, Virginia, United States
🇺🇸
UVA CARE Richmond, Richmond, Virginia, United States

SIS Multicenter Study of Duration of Antibiotics for Intraabdominal Infection

Phase 3

Completed

Conditions: Peritonitis

Interventions: Other: duration of antibiotics

First Posted Date: 2008-04-14

Last Posted Date: 2018-05-22

Lead Sponsor: University of Virginia

Target Recruit Count: 518

Registration Number: NCT00657566

Locations: 🇺🇸
University of Virginia, Charlottesville, Virginia, United States
🇺🇸
Washington Universtiy, Saint Louis, Missouri, United States
🇺🇸
Univestity of Kansas, Kansas City, Kansas, United States

and more 20 locations

Effects of Sho-saiko-to, a Herbal Formula, in Reducing Viral Load in Hepatitis C

Phase 1

Withdrawn

Conditions: Hepatitis C Virus

Interventions: Drug: standardized herbal formula, Sho-saiko-to (SST)
Other: placebo capsule identical to the active herbal formula

First Posted Date: 2008-03-11

Last Posted Date: 2015-06-25

Lead Sponsor: University of Virginia

Registration Number: NCT00633230

Assessment of Changes in Renal Cortical and Medullary Blood Flow by Contrast Ultrasound

Not Applicable

Conditions: Kidney

First Posted Date: 2008-03-07

Last Posted Date: 2008-08-07

Lead Sponsor: University of Virginia

Target Recruit Count: 20

Registration Number: NCT00631553

Locations: 🇺🇸
University of Virginia Health System, Charlottesville, Virginia, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy